Explore more publications!

Press Releases

KEFA Valve: Building the Future of Global Infrastructure as a China Leading Gate Valve Manufacturer
Polypropylene Disposable Food Containers Market Trends 2026-35
The 2026 Powerhouse: Why Shandong Hesper Ranks Among China's Top 10 Industrial Hose Manufacturers
Consumer Electronics Market Size to Reach USD 1,949 Billion by 2035
Youfa Group: Building the Global Infrastructure Backbone as a Global Leading Carbon Steel Pipe Manufacturer
AI in Wound Care Market Projected to Achieve a 35.03% CAGR, Expanding from USD 0.64 Billion to USD 12.9 Billion by 2034
Automated Ophthalmic Perimeters Market is expected to reach US$ 389.52 Million by 2033 | DataM Intelligence
Health & Wellness Industry in 2026: Key Trends and Transformations
Manufacturing Tech Survey Reveals Progress in AI Adoption & Digital Transformation Amid Economic & Trade Pressures
Carlos Moreira Presented SEALSQ’s Sovereign Root-to-Quantum Platform at Tech&Fest
Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

Additive Manufacturing Market to Surpass USD 133.48 Billion by 2032, Fueled by Metal 3D Printing Growth
Tesla’s European EV Sales Plunge

Tesla’s European EV Sales Plunge

Poland Seeks EU Action After Ukraine’s Ban on Steel Scrap Exports

Poland Seeks EU Action After Ukraine’s Ban on Steel Scrap Exports

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
France Opposes EU Proposal Regarding UK Missiles

France Opposes EU Proposal Regarding UK Missiles

Chinese Top 3 Passenger Elevator Manufacturers 2026 - Leading the Global Elevator Market

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions